Hypoxia reduces hormone responsiveness of human breast cancer cells

被引:72
作者
Kurebayashi, J
Otsuki, T
Moriya, T
Sonoo, H
机构
[1] Kawasaki Med Sch, Dept Breast & Thyroid Surg, Okayama 7010192, Japan
[2] Kawasaki Med Sch, Dept Hyg, Okayama 7010192, Japan
[3] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 2001年 / 92卷 / 10期
关键词
hypoxia; breast cancer; estrogen receptor; hypoxia-inducible factor-1 alpha; hormone resistance;
D O I
10.1111/j.1349-7006.2001.tb01064.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Resistance to hormonal therapy frequently occurs following successful treatment in breast cancer. The mechanism responsible for this acquired resistance is still unknown. It has been suggested that a hypoxic tumor microenvironment promotes malignant progression of cancer, i.e., hypoxia may promote estrogen-independent growth (a more malignant phenotype) of breast cancer. To clarify this hypothesis, the effects of hypoxia on the growth responses to hormonal agents and the expression levels of estrogen receptor (ER)-alpha and progesterone receptor (PgR) were investigated in two human breast cancer cell lines, ML-20 and KPL-1. The expression level of ER-alpha was significantly decreased by hypoxia (1% O-2) in a time-dependent manner in both cell lines. Hypoxia also significantly reduced the growth-promoting effect of estradiol (E-2) and the growth-inhibitory effects of an antiestrogen, ICI 182 780, and a progestin, medroxyprogesterone acetate, in both cell lines. In addition, hypoxia markedly suppressed the induction of PgR mRNA and protein by E2 in both cell lines. To clarify further the effect of hypoxia on ER-alpha expression, the expression levels of hypoxia-inducible factor-1 alpha (HIF-1 alpha), a marker of hypoxia and ER-alpha were immunohistochemically examined in 36 breast cancer specimens. ER-alpha expression (both its proportion and intensity) was significantly lower in nuclear HIF-1 alpha -positive tumors than in negative tumors. These findings indicate that hypoxia down-regulates ER-alpha expression as well as ER-alpha function in breast cancer cells. These processes may lead to an acquired resistance to hormonal therapy in breast cancer.
引用
收藏
页码:1093 / 1101
页数:9
相关论文
共 28 条
[1]  
Birner P, 2000, CANCER RES, V60, P4693
[2]   Levels of hypoxia-inducible factor-1α during breast carcinogenesis [J].
Bos, R ;
Zhong, H ;
Hanrahan, CF ;
Mommers, ECM ;
Semenza, GL ;
Pinedo, HM ;
Abeloff, MD ;
Simons, JW ;
van Diest, PJ ;
van der Wall, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :309-314
[3]  
Brown JM, 1999, CANCER RES, V59, P5863
[4]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[5]  
Evans SM, 1997, CANCER RES, V57, P5155
[6]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[7]  
GAGLIARDI A, 1993, CANCER RES, V53, P533
[8]  
Gasparini G, 1999, CANCER J SCI AM, V5, P101
[9]   Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J].
Harvey, JM ;
Clark, GM ;
Osborne, CK ;
Allred, DC .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1474-1481
[10]   Antiestrogens: Mechanisms of action and resistance in breast cancer [J].
Katzenellenbogen, BS ;
Montano, MM ;
Ekena, K ;
Herman, ME ;
McInerney, EM .
BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (01) :23-38